تمامی مطالب علمی این سایت، به تایید تیم علمی پزشکی داروسازی دکتر عبیدی رسیده است.

Blood 2012; DASISION; Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia 2-year follow-up from a randomized phase 3 trial (DASISION)

Blood 2012; DASISION; Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia 2-year follow-up from a randomized phase 3 trial (DASISION)

۱۴۰۰/۰۲/۱۹

Blood 2012; DASISION; Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia 2-year follow-up from a randomized phase 3 trial (DASISION)

Blood 2012; DASISION; Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia 2-year follow-up from a randomized phase 3 […]
۱۴۰۰/۰۲/۱۹

NCCN Chronic Myeloid Leukemia

NCCN Chronic Myeloid Leukemia
۱۴۰۰/۰۲/۱۹

N Engl J Med 2017; LATITUDE; Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

N Engl J Med 2017; LATITUDE; Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
۱۴۰۰/۰۲/۱۹

NCCN Prostate Cancer

NCCN Prostate Cancer
۱۴۰۰/۰۲/۱۳

Tofacitinib in AS phase 3

Tofacitinib in AS phase 3
۱۴۰۰/۰۲/۱۳

PMS Trial

PMS Trial
۱۴۰۰/۰۲/۱۳

Oral Sync B 2017

Oral Sync B 2017
۱۴۰۰/۰۲/۱۳

ORAL Sequel 9.5 years 8

ORAL Sequel 9.5 years 8
۱۴۰۰/۰۲/۱۳

ORAL Strategy 2017-7

ORAL Strategy 2017-7
۱۴۰۰/۰۲/۱۳

Oral start 2014-6

Oral start 2014-6
Telegram
ШµЩЃШ­Щ‡ Ш§ЫЊЩ†ШіШЄШ§ЪЇШ±Ш§Щ… ШЇЪ©ШЄШ± Ш№ШЁЫЊШЇЫЊ
پزشکان